Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

Arjang Djamali, Brenda L. Muth, Jose Torrealba, Debra Bloom, Karen M. Miller, David Lorentzen, Hans W. Sollinger, John D. Pirsch, Joshua D. Mezrich

Research output: Contribution to journalArticle

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)485-490
Number of pages6
JournalClinical transplants
StatePublished - 2009

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Djamali, A., Muth, B. L., Torrealba, J., Bloom, D., Miller, K. M., Lorentzen, D., Sollinger, H. W., Pirsch, J. D., & Mezrich, J. D. (2009). Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation. Clinical transplants, 485-490.